ABPO on OTC
Abpro Holdings, Inc.
$0.40 up 0.01 (3.36%)Price as of Oct 15, 2026 at 17:33 UTC
Last updated Oct 16, 2026.
Overview
Compare with Titan Pharmaceuticals, aTyr Pharma or WINDTREE THERAPEUTICS INC /DE/, or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2024
Where the money goes
Where each dollar of revenue went, fiscal 2024
- Research and development100¢$3.0M
Out of $183.0K in revenue.54 The company lost money this year.
Financial statements
Every line of the income statement in the latest annual report, as filed.4
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Research and development | $989.0K | $3.0M |
| General and administrative | $7.5M | $7.1M |
| Total operating expenses | $8.5M | $10.1M |
| Loss from operations | -$8.5M | -$9.9M |
| Derecognition of Mabwell liability (see Note 19) | $3.3M | |
| Gain on reversal of excise taxes payable (see Note 10) | $4.4M | |
| Other income (see Note 2) | $3.6M | |
| Change in fair value of forward purchase agreement asset | -$23.0K | -$339.0K |
| Change in fair value of SEPA put rights asset | -$92.0K | -$312.0K |
| Change in fair value of embedded derivative liability | -$773.0K | -$11.0K |
| Gain on extinguishment of accrued liabilities | $200.0K | $173.0K |
| Loss on settlement of convertible notes | -$358.0K | |
| Interest income | $33.0K | $9.0K |
| Interest expense | -$1.1M | -$387.0K |
| Total other income, net | $5.6M | $2.7M |
| Net loss | -$2.9M | -$7.2M |
| Deemed dividend resulting from the warrant down round | -$10.2M | |
| Net loss attributable to common stockholders | -$2.9M | -$17.4M |
| Basic (in Dollars per share) | -$1.30 | -$22.31 |
| diluted (in Dollars per share) | -$1.30 | -$22.31 |
| Weighted average shares outstanding - basic (in Shares) | 2.2M shares | 780.3K shares |
| Weighted average shares outstanding - diluted (in Shares) | 2.2M shares | 780.3K shares |
Every line of the balance sheet in the latest annual report, as filed.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash | $67.0K | $2.9M | |
| Accounts receivable | $183.0K | $183.0K | |
| Prepaid expenses and other current assets | $480.0K | $446.0K | |
| Forward purchase agreement asset | $155.0K | ||
| Security deposits | $55.0K | ||
| SEPA put rights asset | $96.0K | ||
| Restricted cash | $15.0K | $142.0K | |
| Total current assets | $896.0K | $3.8M | |
| Property and equipment, net | $37.0K | ||
| Right-of-use asset - operating lease | $418.0K | ||
| Security deposits | $66.0K | ||
| Patents, net | $167.0K | $176.0K | |
| SEPA put rights asset | $188.0K | ||
| Total assets | $1.1M | $4.7M | |
| Accounts payable | $5.3M | $3.9M | |
| Accrued expenses | $3.9M | $7.5M | |
| Excise taxes payable | $4.4M | ||
| Operating lease liability, current | $456.0K | ||
| Income taxes payable | $366.0K | ||
| Convertible notes | $2.7M | ||
| Embedded derivative liability | $80.0K | ||
| Total current liabilities | $9.3M | $19.6M | |
| Additional paid-in capital | $110.2M | $100.6M | |
| Accumulated deficit | -$119.0M | -$116.1M | |
| Total Abpro Holdings, Inc.'s stockholders' deficit | -$8.8M | -$15.5M | |
| Non-controlling interest | $549.0K | $549.0K | |
| Total stockholders' deficit | -$8.3M | -$14.9M | -$88.4M |
| Total liabilities and stockholders deficit | $1.1M | $4.7M | |
| Preferred stock, par value (in Dollars per share) | $0.00 | $0.00 | |
| Preferred stock, shares authorized (in Shares) | 1.0M shares | 1.0M shares | |
| Preferred stock, shares issued (in Shares) | 0 shares | 0 shares | |
| Preferred stock, shares outstanding (in Shares) | 0 shares | 0 shares | |
| Common stock, par value (in Dollars per share) | $0.00 | $0.00 | |
| Common stock, shares authorized (in Shares) | 110.0M shares | 110.0M shares | |
| Common stock, shares issued (in Shares) | 2.7M shares | 1.7M shares | |
| Common stock, shares outstanding (in Shares) | 2.7M shares | 1.7M shares | |
| Treasury stock, shares cost (in Shares) | 0 shares | 32.8K shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.4
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net loss | -$2.9M | -$7.2M |
| Depreciation and amortization expense | $21.0K | $74.0K |
| Share-based compensation | $1.5M | $1.9M |
| Amortization of operating lease right-of-use assets | $418.0K | $548.0K |
| Noncash interest expense | $854.0K | $39.0K |
| Loss on settlement of convertible notes | $358.0K | |
| Derecognition of Mabwell liability (see Note 19) | -$3.3M | |
| Gain on reversal of excise taxes payable (see Note 10) | -$4.4M | |
| Other income (see Note 2) | -$3.6M | |
| Amortization of debt discount | $160.0K | |
| Change in fair value of forward purchase agreement asset | $23.0K | $339.0K |
| Change in fair value of SEPA put rights asset | $92.0K | $312.0K |
| Change in fair value of embedded derivative liability | $773.0K | $11.0K |
| Gain on extinguishment of accrued liabilities | -$200.0K | -$173.0K |
| Accounts receivable | -$95.0K | |
| Prepaid expenses and other current assets | -$34.0K | -$233.0K |
| Security deposits | $11.0K | |
| Accounts payable | $1.2M | -$860.0K |
| Accrued expenses | $197.0K | $378.0K |
| Excise taxes payable | $57.0K | |
| Income taxes payable | -$366.0K | |
| Operating lease liability | -$456.0K | -$566.0K |
| Net cash used in operating activities | -$6.0M | -$9.0M |
| Proceeds from sales of property and equipment | $26.0K | |
| Net proceeds from the Merger | $490.0K | |
| Net proceeds from PIPE financing | $10.4M | |
| Cash transferred into escrow pursuant to Forward Purchase Agreement | -$1.1M | |
| Proceeds from settlement of Forward Purchase Agreement | $132.0K | |
| Proceeds from issuance of notes payable - related party | $5.9M | |
| Payment of notes payable - related party | -$5.7M | |
| Proceeds from issuance of Convertible Notes, net of issuance costs | $1.8M | $2.8M |
| Proceeds from issuance of Note payable | $553.0K | |
| Payments on Note payable | -$553.0K | |
| Issuance of Advance Shares | $1.1M | |
| Payment of offering costs | -$1.4M | |
| Repayment of finance lease liabilities | -$17.0K | |
| Net cash provided by financing activities | $3.1M | $11.2M |
| Net change in cash and restricted cash | -$2.9M | $2.1M |
| Interest paid | $21.0K | $1.0K |
| Issuance Cost for Advance Shares included in accrued expenses | $77.0K | |
| Fair value of common stock issued for services | $161.0K | |
| Common stock issued in settlement of convertible notes and embedded derivative liability | $5.9M | |
| Reclassification of RSU liability into equity | $396.0K | |
| Fair value of embedded derivative liability at issuance date | $93.0K | $69.0K |
| Deferred offering costs included in accounts payable | $436.0K | |
| Reclassification of residual value guarantees under finance lease to accrued expense | $113.0K | |
| ACAB liabilities assumed in the Merger, net | $6.6M | |
| Conversion of notes payable-related parties into common stock of New Abpro | $2.0M | |
| Conversion of pre-merger preferred stock of Abpro into common stock of New Abpro | $75.6M | |
| SEPA commitment fee paid in common stock shares | $327.0K |
Former names
- Atlantic Coastal Acquisition Corp. IIDec 2, 2021 to Nov 12, 20243
Recent filings
- Sep 30, 202625-NSE
- Sep 1, 20268-K CURRENT REPORT
- Aug 25, 20268-K CURRENT REPORT
- Aug 14, 202610-Q QUARTERLY REPORT
- Aug 11, 2026SCHEDULE 13G/A
- Jun 4, 20268-K CURRENT REPORT
- May 20, 202610-Q QUARTERLY REPORT
- May 15, 2026NT 10-Q NOTIFICATION OF LATE FILING
- May 1, 202610-K/A AMENDMENT NO. 1 TO FORM 10-K
- Apr 15, 202610-K ANNUAL REPORT
- Mar 31, 2026NT 10-K NOTIFICATION OF LATE FILING
- Feb 20, 20268-K CURRENT REPORT
- Feb 11, 20268-K CURRENT REPORT
- Feb 9, 2026SCHEDULE 13G
- Feb 3, 20268-K CURRENT REPORT
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2Yahoo FinanceABPO quote
- 3
- 4
- 5
- 6
- 7
- 8
- 9